Market is over-sold and might be a market low.
- A Related account sold a small amount of KRRGF and bought LABU
DIREXION SHARES ETF TRUST DIREXION DAILY S&P BIOTECH BULL 3X
LABU is a levered ETF of Genomic/Biotech stocks 3X levered so make a note of that.
You know by now that I treat KRRGF (Karora Resources)* the same as a cash (resource), so I sold a small amount to buy into LABU. I have been stalking this idea for a while. It was over $160 a year ago and now about $13.75.
Love the genomic/biotech opportunity but never could mentally pony up and pay what was being asked.
This is an initial position. Not sure if it is a trade or something more.
February 24, 2022, written by Tom Linzmeier
LOTM Research & Consulting Service
* An account related to LOTM holds a position in this security.
Neither LOTM nor Tom Linzmeier is a Registered Investment Advisor.
Please refer to our web site for full disclosure at www.LivingOffTheMarket.com ZTA Capital Group, Inc.
To Unsubscribe please select “return” and type Unsubscribe in the subject line.
